Have you wondered whether cannabinoids are relevant to you?
Do you want to find out the objective facts behind the media headlines?
Medical cannabis and cannabis-based products have been making the headlines for a while now, as a form of treatment for some cancers. This may well have left you confused,
wondering what these developments might mean for you – now and in the future.
In this webinar you will have a unique opportunity to hear the evidence from leading clinical
experts in the field of neurology and neuro-oncology. We’re very privileged to have the science behind Releaf join us to share the evidence-based context to cannabinoids and their role in the oncology clinical pathway.
Releaf is a private medicinal cannabis clinic, which transforms how patients access, use, and experience medicinal cannabis. There is no evidence to suggest that this is a cure for brain tumours, but there may be other uses.
The medical director and clinical oncologist, Sue Clenton, Michal Modestowicz (consultant
neurologist) and Kim Kaye (lead nurse at Releaf and palliative care nurse) will walk us
through:
- The history of medical cannabis
- The science
- Symptoms of brain tumours where cannabinoids may be able to help with and the types
- Sympton control including epilepsy
- Clinical trials
- How to access medical cannabis
- The future for cannabinoids.
Releaf Cannabinoids
For everyone to get a chance to ask questions and make the most of the session, places are
limited, so reserve yours now.
